CLLS
Price
$3.54
Change
+$0.01 (+0.28%)
Updated
Feb 4 closing price
Capitalization
379.3M
34 days until earnings call
Intraday BUY SELL Signals
PMVP
Price
$1.03
Change
-$0.05 (-4.63%)
Updated
Feb 4 closing price
Capitalization
55.07M
27 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLLS vs PMVP

Header iconCLLS vs PMVP Comparison
Open Charts CLLS vs PMVPBanner chart's image
Cellectis SA
Price$3.54
Change+$0.01 (+0.28%)
Volume$78.97K
Capitalization379.3M
PMV Pharmaceuticals
Price$1.03
Change-$0.05 (-4.63%)
Volume$278.89K
Capitalization55.07M
CLLS vs PMVP Comparison Chart in %
CLLS
Daily Signal:
Gain/Loss:
PMVP
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CLLS vs. PMVP commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLLS is a StrongBuy and PMVP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (CLLS: $3.54 vs. PMVP: $1.03)
Brand notoriety: CLLS and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLLS: 100% vs. PMVP: 100%
Market capitalization -- CLLS: $379.3M vs. PMVP: $55.07M
CLLS [@Biotechnology] is valued at $379.3M. PMVP’s [@Biotechnology] market capitalization is $55.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLLS’s FA Score shows that 1 FA rating(s) are green whilePMVP’s FA Score has 0 green FA rating(s).

  • CLLS’s FA Score: 1 green, 4 red.
  • PMVP’s FA Score: 0 green, 5 red.
According to our system of comparison, CLLS is a better buy in the long-term than PMVP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLLS’s TA Score shows that 4 TA indicator(s) are bullish while PMVP’s TA Score has 4 bullish TA indicator(s).

  • CLLS’s TA Score: 4 bullish, 6 bearish.
  • PMVP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PMVP is a better buy in the short-term than CLLS.

Price Growth

CLLS (@Biotechnology) experienced а -12.81% price change this week, while PMVP (@Biotechnology) price change was -15.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.41%. For the same industry, the average monthly price growth was +1.41%, and the average quarterly price growth was +32.47%.

Reported Earning Dates

CLLS is expected to report earnings on Mar 11, 2026.

PMVP is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLLS($379M) has a higher market cap than PMVP($55.1M). PMVP YTD gains are higher at: -17.600 vs. CLLS (-26.860). CLLS has higher annual earnings (EBITDA): -6.07M vs. PMVP (-91.99M). CLLS has more cash in the bank: 190M vs. PMVP (129M). PMVP has less debt than CLLS: PMVP (931K) vs CLLS (92.8M). CLLS has higher revenues than PMVP: CLLS (75.3M) vs PMVP (0).
CLLSPMVPCLLS / PMVP
Capitalization379M55.1M688%
EBITDA-6.07M-91.99M7%
Gain YTD-26.860-17.600153%
P/E RatioN/AN/A-
Revenue75.3M0-
Total Cash190M129M147%
Total Debt92.8M931K9,968%
FUNDAMENTALS RATINGS
CLLS: Fundamental Ratings
CLLS
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLLSPMVP
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 14 days ago
77%
Bullish Trend 9 days ago
76%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
66%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 7 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CLLS
Daily Signal:
Gain/Loss:
PMVP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEBZY0.41N/A
N/A
Anadolu Efes Biracilik Ve Malt AS
TCEYF12.15N/A
N/A
TC Energy Corp.
MHGVY23.32-0.04
-0.16%
Mowi ASA
IBATF0.11N/A
-1.50%
International Battery Metals Ltd.
GSCCF0.11N/A
-3.47%
Ioneer Ltd.

CLLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLLS has been closely correlated with CMVLF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLLS jumps, then CMVLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLLS
1D Price
Change %
CLLS100%
+0.28%
CMVLF - CLLS
82%
Closely correlated
N/A
SLN - CLLS
43%
Loosely correlated
-11.16%
MDGL - CLLS
40%
Loosely correlated
-0.80%
PMVP - CLLS
38%
Loosely correlated
-4.63%
AXON - CLLS
36%
Loosely correlated
-4.57%
More

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with KRRO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then KRRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
-4.63%
KRRO - PMVP
45%
Loosely correlated
-3.46%
TPST - PMVP
44%
Loosely correlated
-1.24%
VTGN - PMVP
44%
Loosely correlated
-3.20%
ZLAB - PMVP
44%
Loosely correlated
+3.47%
AVXL - PMVP
43%
Loosely correlated
-5.92%
More